Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Systemic Isotretinoin on Serum Irisin in Acne Vulgaris
NCT05869188Completed
- Sponsor
- South Valley University
- Start
- Jun 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of isotretinoin in acne vulgaris (3 arms), sponsored by South Valley University. Primary endpoint: Serum Irisin Level at 3 months. Started Jun 2023; status: completed.
02
Drugs
isotretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT05869188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05869188.